Elixir Good Mood - Mood & Anti-depression

1 to 3ml per daydiluted in a drink (water, juice, etc.).

• Mild/seasonal depression: start the treatment at the beginning of autumn and take for 1 to 3 months depending on symptoms
• Emotional lability before and/or during menstruation:3ml per day and up to 5ml on “difficult” days. CombinePremenstrual Harmony Elixir and/orHormonal Balance P
• Accompany during adietor help toreduce sugar cravings: 2ml around 5-6pm then in the evening 1 to 2ml depending on the intensity. If a lot of anxiety associate withElixir The Relaxants
• To accompanyquitting smoking, alcohol or other addictions: 1.5ml 3 times a day for a 3 to 6 month treatment.
• Postpartum depression: 3ml per day and up to 5ml on “difficult” days, do not breastfeed without the advice of a healthcare professional.

Precautions for use:

Not recommended for children under 12 years old, during pregnancy and breastfeeding,to people on antidepressant treatment(especially fromSSRI type – selective serotonin reuptake inhibitors:Prozac;Deroxat, Divarius, Paxil,Zoloft,Seropram, Celexa,Seroplex, Cipralex,Priligy,Floxyfral).
Do not use for more than 6 months without the advice of a healthcare professional. People taking medication shouldtake the elixir at least 60 minutes after taking the medication(may reduce hepatic metabolism of drugs)

Elixir for 3ml of which the equivalent of 600mg of dry plant (PS):

• Griffonia*–Griffonia simplicifolia– Seed 210mg PS
• Ashwagandha*–Withania simplicifolia– Root – 180mg PS
• Jasmine*–Jasminus communis– Aerial part 120mg PS
• St. John's Wort*–Hypericum perforatum– Aerial part 90mg PS

***Alcohol* 55° organic (for the normal version)

Purified water

***Organic vegetable glycerin* for the alcohol-free version 55%

*Product from Organic Agriculture

Expertise Scientifique & Rigueur Académique

La formulation de nos élixirs repose sur une sélection rigoureuse d'actifs dont l'efficacité et la sécurité sont validées par la littérature scientifique mondiale et les monographies de référence (EMA, Cochrane, PubMed).

Griffonia simplicifolia (5-HTP)

• Maffei ME. (2021). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis and Pharmacology. Molecules. Une revue complète sur la bio-synthèse de la sérotonine.Consulter l'étude (PubMed)
• Weinberg-Wolf H, et al. (2018). The effects of 5-hydroxytryptophan on attention and central serotonin neurochemistry. Neuropsychopharmacology.Consulter l'étude (PMC)
• Jangid P. et al. (2013). Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine. Asian J Psychiatr.Consulter l'étude (PubMed)

Ashwagandha (Withania somnifera)

• Pratte et al. (2014). An alternative treatment for anxiety: a systematic review of Ashwagandha. Une analyse systématique confirmant l'efficacité des adaptogènes.Consulter l'étude (PubMed)
• Kelgane SB, et al. (2020). Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients. J Ethnopharmacol. Consulter l'étude (PubMed 32818573)
• Deshpande A, et al. (2020). A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha extract on sleep quality. Sleep Med. Consulter l'étude (PubMed 32540634)
• Chandrasekhar K. et al. (2012). A prospective, randomized double-blind, placebo-controlled study of ashwagandha root in reducing stress and anxiety. Indian J Psychol Med. Consulter l'étude (PubMed 23439798)
• Chandrasekhar K, et al. (2012). Safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety. Indian J Psychol Med.Consulter l'étude (PubMed 23439798)
• Langade D, et al. (2021). Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients. J Ethnopharmacol. Étude pivotale sur la régulation du repos et du bien-être psychique.Consulter l'étude (PubMed 32818573)

Millepertuis (Hypericum perforatum)

• Linde K. et al. (2008). St John's wort for major depression (Cochrane Review). Cochrane Database Syst Rev. La référence mondiale sur le sujet.Consulter l'étude (PubMed)
• Ng QX et al. (2017). Clinical use of Hypericum perforatum in depression: A meta-analysis. J Affect Disord.Consulter l'étude (PubMed)
• Saqulain S., et al. (2025).Medicinal plants as sources of bioactive compounds: A review of Hypericum perforatum (St. John's Wort) phytochemistry and its role in mental health therapy.World Journal of Pharmaceutical and Life Sciences (WJPLS). Une revue de synthèse majeure sur les mécanismes neuroprotecteurs et antidépresseurs. Consulter l'étude
• François D. (2010). Le millepertuis : de la plante au médicament : usages traditionnels et interactions médicamenteuses.Thèse de Doctorat en Pharmacie, Université de Lorraine (Nancy).Consulter le document (HAL 01738934)
• Oliveira AI, et al. (2016).Neuroprotective Activity of Hypericum perforatum and Its Major Components.Frontiers in Plant Science. Étude clé sur les capacités antioxydantes et protectrices des neurones. Consulter l'étude (PubMed)